Potassium binding as RAASi enabling therapy: applying recent insights into practice10' education - July 18, 2022 - Aaron Wong, MD - Bridgend, UK
Video navigation menu
- Relationship between potassium level and mortality 00:28
- Guidelines on management of hyperkalemia in patients on RAASi therapy 02:05
- Clinical studies with novel potassium binders 02:27
- Evaluation of SZC enabling initiation and up-titration of RAASi in HFrEF 03:43
- Summary 09:05
This lecture by Aaron Wong was part of the EBAC-accredited symposium "Clinical dilemmas in heart failure: Weighing the balance of RAASi and hyperkalaemia" held during the ESC Heart Failure 2022 congress.
Aaron Wong, MD is consultant cardiologist and general physician at the Princess of Wales Hospital in Bridgend, Wales, UK. He is also honorary lecturer at the University of Cardiff, UK.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from AstraZeneca.